Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of NSRX will rise by +0.15% over the next 2 Weeks and hit $3.07 by Tuesday, June 30, 2026. In that time frame, NSRX's share price is expected to range between $2.83 and $3.33.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Jun 30, 2026 | 2.83 | 3.07 | 3.33 |
| Jun 29, 2026 | 2.96 | 3.18 | 3.42 |
| Jun 26, 2026 | 2.97 | 3.20 | 3.44 |
| Jun 25, 2026 | 3.08 | 3.31 | 3.55 |
| Jun 24, 2026 | 2.92 | 3.13 | 3.40 |
| Jun 23, 2026 | 2.84 | 3.06 | 3.31 |
| Jun 22, 2026 | 2.95 | 3.17 | 3.41 |
| Jun 19, 2026 | 2.95 | 3.19 | 3.43 |
| Jun 18, 2026 | 3.08 | 3.30 | 3.54 |
| Jun 17, 2026 | 2.89 | 3.12 | 3.35 |
NSRX shares rose +0.33% in Wednesday, June 17, 2026's trading session, rising from a previous close of $3.07 to move at $3.08. The stock demonstrated notable intraday movement (see NSRX's key stats for a full breakdown), fluctuating between $3.00 and $3.18, a +6.00% trading range. While recent weeks have seen some volatility, NSRX has managed to secure a -4.94% drop over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 21.02K shares changing hands, 15.23K fewer than the previous session. This amounted to $64.73K in total market activity.
Will NSRX Continue Its Upward Trend?
According to analyst ratings and projections for NSRX, Nasus Pharma Ltd. shares are anticipated to increase by +7.46%, potentially reaching $3.33 per share by June 30, 2026. Short-term technical indicators currently suggest a neutral sentiment for NSRX. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 15 positive trading days within the past 30 sessions. Based on the NSRX stock forecast, now is a good time to buy NSRX stock because its current trading price is +0.18% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on NSRX covering social and institutional perspectives.
NSRX Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into NSRX's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 50.27% to 51.62%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 46.19%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 45.02%, maintains a neutral outlook for the long term. Insights into NSRX's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Nasus Pharma Short-Term Forecasts
NSRX Forecast For Next 5 Days
Our algorithm anticipates Nasus Pharma (NSRX) stock could hit $3.14 by Jun 24, 2026. This represents a +1.87% fall from today's price, following a -10.68% change over the past five days.
NSRX Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Nasus Pharma Ltd. (NSRX) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $3.40, which would mean a +10.39% increase from the current price of $3.08. Projections for this period range from a high of $4.05 to a low of $2.80.
NSRX Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Nasus Pharma's price over the next three months point to a rise. NSRX stock is expected to peak at $9.87 on Jun 17, 2026 before potentially dipping to $4.25 on Sep 16, 2026. On average, NSRX is likely to trade around $6.43 in the coming 90 days.
Nasus Pharma Stock Forecast 2025
Based on our predictive models, Nasus Pharma (NSRX) is expected to trade between $2.37 and $9.87 throughout 2026. This would result in an average price of $4.89, potentially offering investors a +58.77% return from current levels.
Nasus Pharma Ltd. Monthly Forecast 2026–2027
June 2026
According to our latest forecast models, Nasus Pharma Ltd. (NSRX) is positioned to show a strong performance in June 2026. The price is predicted to move between $7.86 and $9.87, settling at an average of $8.87. This could translate to a +187.99% gain.
July 2026
Based on current market signals, Nasus Pharma Ltd. is projected to trend july 2026. We forecast a trading range from $6.03 to $7.98, with a likely average price of $7.16. Investors could expect a potential return of +132.47%.
August 2026
Our predictive algorithms indicate Nasus Pharma Ltd. stock may see a shift in August 2026. The expected range spans $4.62–$6.45, with an average target of $5.43. This represents a positive outlook and a possible gain of +76.30%.
September 2026
Analyzing established trends, Nasus Pharma Ltd. looks set to move in September 2026. Projections place the stock between $3.87 and $5.34, averaging around $4.58. This suggests a +48.70% gain from current levels.
October 2026
Market indicators suggest Nasus Pharma Ltd. could experience notable changes during October 2026. Prices could fluctuate within $3.88 to $4.35, with a midpoint forecast of $4.11. The stock might deliver a +33.44% gain.
November 2026
Forecasting for November 2026, models estimate that Nasus Pharma Ltd. may undergo key fluctuations. If trends hold, the stock might trade between $2.59 and $4.10, averaging $3.57. This signals a positive trajectory with potential returns around +15.91%.
December 2026
According to our latest forecast models, Nasus Pharma Ltd. (NSRX) is positioned to show a strong performance in December 2026. The price is predicted to move between $2.37 and $2.99, settling at an average of $2.65. This could translate to a -13.96% loss.
January 2027
Based on current market signals, Nasus Pharma Ltd. is projected to trend january 2027. We forecast a trading range from $1.61 to $2.70, with a likely average price of $1.99. Investors could expect a potential return of -35.39%.
February 2027
Our predictive algorithms indicate Nasus Pharma Ltd. stock may see a shift in February 2027. The expected range spans $1.22–$1.75, with an average target of $1.42. This represents a cautious outlook and a possible loss of -53.90%.
March 2027
Analyzing established trends, Nasus Pharma Ltd. looks set to move in March 2027. Projections place the stock between $0.47 and $1.40, averaging around $0.94. This suggests a -69.48% loss from current levels.
April 2027
Market indicators suggest Nasus Pharma Ltd. could experience notable changes during April 2027. Prices could fluctuate within $0.46 to $0.85, with a midpoint forecast of $0.66. The stock might deliver a -78.57% loss.
May 2027
Forecasting for May 2027, models estimate that Nasus Pharma Ltd. may undergo key fluctuations. If trends hold, the stock might trade between $0.45 and $0.77, averaging $0.60. This signals a cautious trajectory with potential returns around -80.52%.
June 2027
According to our latest forecast models, Nasus Pharma Ltd. (NSRX) is positioned to show a strong performance in June 2027. The price is predicted to move between $0.35 and $0.68, settling at an average of $0.50. This could translate to a -83.77% loss.
NSRX's history of dividends and stock splits also plays a role in long-term investor confidence.